Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2014
08/26/2014US8815821 Double-stranded oligonucleotides
08/26/2014US8815501 Flavivirus NS1 subunit vaccine
08/26/2014US8815295 Anti respiratory syncytial virus peptide functionalized gold nanoparticles
08/26/2014US8815245 Method of treating viral diseases
08/26/2014US8815239 Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X
08/26/2014CA2765852C Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections
08/26/2014CA2615666C Novel macrocyclic inhibitors of hepatitis c virus replication
08/26/2014CA2604686C (1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as hiv viral repliation inhibitors
08/26/2014CA2530797C Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird)
08/26/2014CA2476755C Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
08/26/2014CA2467309C Type iii secretion pathway in aeromonas salmonicida, and uses therefor
08/26/2014CA2373236C Combination neisserial compositions
08/21/2014WO2014127378A2 Design of short oligonucleotides as vaccine adjuvants and therapeutic agents
08/21/2014WO2014126921A1 Monoclonal antibodies that neutralize norovirus
08/21/2014WO2014126594A1 Treatment of evolving bacterial resistance diseases including klebsiella pneumoniae with liposomally formulated glutathione
08/21/2014WO2014125075A1 Albicidin derivatives, their use and synthesis
08/21/2014WO2014124757A1 Pyrrolotriazine derivatives as pi3k inhibitors
08/21/2014WO2014124504A1 Compositions and methods for treating biofilms
08/21/2014WO2014102778A3 Agents for treating genetic diseases resulting from nonsense mutations, and methods for identifying the same
08/21/2014US20140234400 Targeted Lipid-Drug Formulations for Delivery of Drugs to Myeloid and Lymphoid Immune Cells
08/21/2014US20140234362 Defensin-antigen fusion proteins
08/21/2014US20140234318 Tumor specific oligosaccharide epitopes and use thereof
08/21/2014US20140234251 Purine nucleoside analogues for treating flaviviridae including hepatitis c
08/21/2014US20140234225 Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer
08/21/2014DE112012003995T5 Caspofunginpräparat mit geringem Verunreinigungsgehalt, Verfahren zu seiner Herstellung und seine Verwendung Caspofunginpräparat with low impurity content, process for its preparation and its use
08/21/2014DE10066235C5 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene
08/20/2014EP2767543A1 Salts of carbamoyl phosphonic acid esters which act as selective inhibitors of human immunodeficiency virus hiv-1 production
08/20/2014EP2767539A1 Pseudopolymorphic forms of a HIV protease inhibitor
08/20/2014EP2767287A1 Agent for preventing or treating htlv-i associated myelopathy
08/20/2014EP2767284A1 D-Fagomine for the control of inflammatory processes related to an overactivation of the humoral immune response
08/20/2014EP2767275A1 Nortriptyline, haloperidol or prochlorperazine edisylate for use in the treatment of tuberculosis as well as two screening methods
08/20/2014EP2766373A1 Sila analogs of oxazolidinone derivatives and synthesis thereof
08/20/2014EP2766370A1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
08/20/2014EP2766367A1 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and their use as antiviral active substances
08/20/2014EP2766365A1 Antiviral compounds
08/20/2014EP2766021A1 Compounds for the treatment of hepatitis c
08/19/2014US8809542 Salts of benzimidazole compound and use thereof
08/19/2014US8809530 Compositions of protein receptor tyrosine kinase inhibitors
08/19/2014US8809330 Pyrazolo[1,5-A]pyrimidines for antiviral treatment
08/19/2014US8809323 Therapeutic applications of pro-apoptotic benzodiazepines
08/19/2014US8809313 Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
08/19/2014US8809286 Conjugated antimicrobial agents
08/19/2014US8809280 Therapeutic peptides
08/19/2014US8809047 Herpes simplex virus vaccines
08/19/2014US8808669 Gastroretentive, extended release composition of therapeutic agent
08/19/2014CA2690668C Vaccines containing canine parvovirus genetic variants
08/19/2014CA2651285C Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
08/19/2014CA2574477C Alpha-defensins as anthrax immunotherapeutics
08/19/2014CA2411596C Therapeutic agents - ii
08/14/2014WO2014124245A1 Modified glycolipids and methods of making and using the same
08/14/2014WO2014124047A1 Antimicrobial peptides derived from hepatitis b virus core protein arginine-rich domain
08/14/2014WO2014124028A1 Cd47 targeted therapies for the treatment of infectious disease
08/14/2014WO2014123900A1 Anti-cancer and anti-hiv compounds
08/14/2014WO2014123894A1 Macrocyclic compounds as hcv entry inhibitors
08/14/2014WO2014123892A1 Macrocyclic molecules as hcv entry inhibitors
08/14/2014WO2014122660A1 Cd14 inhibitors as an effective treatment for hcv infection
08/14/2014WO2014122303A1 Glucan synthase inhibitors
08/14/2014WO2014122144A1 BISPECIFIC ANTIBODIES AGAINST CD3ε AND BCMA
08/14/2014WO2014122143A1 Method for the selection of antibodies against bcma
08/14/2014WO2014122024A1 Topical antifungal composition for treating onychomycosis
08/14/2014WO2014121634A1 Novel bacterial colony sensing regulator and medical use
08/14/2014WO2014121633A1 Derivative of homoserine lactone, and preparation method and use thereof
08/14/2014WO2014121418A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
08/14/2014WO2014121417A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
08/14/2014WO2014121416A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
08/14/2014WO2014121343A1 Methods of treating microbial infections, including mastitis
08/14/2014WO2014121342A1 Methods of treating topical microbial infections
08/14/2014WO2014096440A3 Albumin composition for preventing and/or reducing formation of peptide fibrils
08/14/2014WO2014096300A3 Antibacterial compounds
08/14/2014US20140227278 Antibodies to human signal peptide-containing proteins
08/13/2014EP2764864A1 Novel anti-hcv agent
08/13/2014EP2763971A1 Preparation of micafungin intermediates
08/13/2014EP2763699A2 Vaccine
08/13/2014EP2763698A1 Liposome compositions comprising an adjuvant that activates or increases the activity of tlr2 and uses thereof
08/13/2014EP2763695A1 Adjuvanted formulations of staphylococcus aureus antigens
08/13/2014EP2763670A1 Reactivation of hiv-1 gene expression to treat persistent hiv infection
08/13/2014EP2763665A2 Antimicrobial compositions and methods employing same
08/13/2014CN103987723A Hcv ns5a的抑制剂 Hcv ns5a inhibitors
08/13/2014CN103987706A 吡啶酮衍生物以及含有吡啶酮衍生物的药物 Pyridinone derivatives, and the drug-containing pyridone derivatives
08/13/2014CN103987404A 衣原体抗原组合物及其用途 Chlamydia antigen composition and use thereof
08/13/2014CN103983627A 作为抗结核病药的吡啶并嘧啶化合物 Anti-TB drugs as pyridine and pyrimidine compounds
08/13/2014CN103981210A 一种牛β-防御素4成熟肽的制备方法及其重组菌和应用 Preparation and application of recombinant bacteria and a cow β- defensin 4 mature peptide
08/13/2014CN103981209A 一种牛β-防御素5成熟肽的制备方法及其重组菌和应用 Preparation and application of recombinant bacteria and a cow β- defensin 5 mature peptide
08/13/2014CN103981192A 表达山羊α干扰素的重组腺病毒及其构建方法和应用 Goat α-interferon expression adenovirus and its construction method and application
08/13/2014CN103981154A 一种铜绿假单胞菌噬菌体及其在水貂出血性肺炎预防中的应用 A Pseudomonas aeruginosa phages and its application in mink prevention of hemorrhagic pneumonia
08/13/2014CN103981153A 伪狂犬病病毒双荧光标记缺失病毒的构建 Pseudorabies virus deletion construct double fluorescently labeled virus
08/13/2014CN103981151A 一种伪狂犬灭活疫苗及其制备方法 Pseudo rabies inactivated vaccine and its preparation method
08/13/2014CN103981139A 一株布鲁氏菌弱毒株及其疫苗 An attenuated strain of Brucella and vaccines
08/13/2014CN103981117A 一株高抗逆性屎肠球菌及其培养方法和应用 A height Enterococcus resistance feces and culture methods and applications
08/13/2014CN103981115A 一株高抗逆性屎肠球菌及其应用 A height resistance feces Enterococcus and its application
08/13/2014CN103980480A 一种接枝药物的聚合物的制备和用途 Preparation and use of a graft polymer of drug
08/13/2014CN103980363A 人巨细胞病毒中和抗体及其应用 HCMV neutralizing antibodies and their application
08/13/2014CN103980352A 一种用于抑制鹅坦布苏病毒感染细胞的多肽及其应用 A method for inhibiting viral infection of cells goose Tanbu Su polypeptide and its application
08/13/2014CN103980348A 一种用于诊断和治疗乙型肝炎的短肽及其应用 A method for the diagnosis and treatment of hepatitis B peptide and its application
08/13/2014CN103980332A 2′-氟-2′-(氟甲基)-2′-脱氧核苷类化合物及其磷酸酯潜药 2'-fluoro-2 '- (trifluoromethyl) -2'-deoxy-nucleoside compound and phosphate ester latent drugs
08/13/2014CN103980318A 含有取代苄基的新型核苷磷酸酯前药及其制备方法和用途 Containing substituted benzyl novel nucleoside phosphate prodrug and its preparation and use
08/13/2014CN103980293A 3-乙烯基-7-（噻唑甲氧亚氨基）头孢烷酸的制备方法 3-ethenyl-7-method (thiazol-methoxy-imino) cephalosporanic acid
08/13/2014CN103980285A 一种吡喃萘醌类抗生素及其制备和应用 One kind pyran naphthoquinone antibiotics and preparation and application
08/13/2014CN103980266A 一种具有抗菌活性的化合物及其制备方法 A method for preparing a compound having antibacterial activity and
08/13/2014CN103980264A 一种氨基吡啶类抗真菌化合物及其制备与应用 An amino pyridine antifungal compounds and their preparation and application
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 1798